IVERIC bio Inc (ISEE) Stock Earnings & Estimates
USA - NASDAQ:ISEE - US46583P1021 - Common Stock
39.95 USD
+0.15 (+0.38%)
39.94 USD
-0.01 (-0.03%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 51.5M 24.70% | 50.9M -1.17% | 210M 312.57% | -100.00% | 10.253M | 115.56M 1,027.08% | 345.93M 199.35% | 615.92M 78.05% | 998.72M 62.15% | 1.381B 38.28% | 1.725B 24.91% | 1.984B 15.01% | |||||
| EBITDA YoY % growth | -122.8M -52.74% | -194.8M -58.63% | 110.8M 156.88% | -60.18M -158.75% | N/A 6.14% | -91.347M -45.01% | -109.926M -29.48% | -176.886M -65.42% | -236.497M -24.62% | -174.783M 26.09% | 48.347M 127.66% | 214.84M 344.37% | 583.76M 171.72% | 1.238B 112.07% | 1.902B 53.63% | 2.471B 29.92% | |
| EBIT YoY % growth | -123.5M -53.42% | -195.6M -58.38% | 108M 155.21% | -60.18M -160.46% | -60.531M 6.13% | -80.435M -44.70% | -112.935M -29.38% | -176.574M -65.49% | -247.949M -30.56% | -184.704M 25.51% | -12.073M 93.46% | 228.93M 1,996.29% | 522.66M 128.31% | 835.31M 59.82% | 1.105B 32.29% | 1.303B 17.92% | |
| Operating Margin | -239.81% | -384.28% | 51.43% | N/A | N/A | N/A | N/A | N/A | -2,418.31% | -159.83% | -3.49% | 37.17% | 52.33% | 60.49% | 64.06% | 65.68% | |
| EPS YoY % growth | -3.02 -2.03% | -5.45 -80.46% | 3.17 158.17% | -1.59 -152.68% | -1.36 18.46% | -1.01 16.28% | -1.11 0.88% | -1.46 -34.51% | -1.84 -21.05% | -1.32 28.10% | -0.03 97.43% | 1.32 3,980.29% | 3.49 164.83% | 4.27 22.19% | 5.09 19.24% | 5.72 12.42% |
All data in USD
| Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 -25.63% | -0.50 -44.26% | -0.46 1.26% | -0.41 23.02% | -0.37 27.72% | -0.28 44.44% | -0.24 47.25% |
| Revenue Q2Q % growth | 3.233M | 8.702M | 10.29M | 20.15M | 33.052M 922.33% | 48.253M 454.50% | |
| EBITDA Q2Q % growth | -76.817M -54.54% | -75.803M -78.65% | -71.267M -13.42% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -69.803M -40.30% | -69.446M -63.36% | -66.144M -5.04% | -48.246M 34.66% | -37.23M 46.66% | -21.93M 68.42% | -9.996M 84.89% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2023 Q2Q % growth | -0.53 -82.76% | -0.48 | -0.05 | -11.29% |
| Q4 2022 Q2Q % growth | -0.47 -62.07% | -0.38 | -0.09 | -22.88% |
| Q3 2022 Q2Q % growth | -0.35 -52.17% | -0.41 | 0.06 | 15.07% |
| Q2 2022 Q2Q % growth | -0.41 -28.12% | -0.32 | -0.09 | -27.83% |
| Q1 2022 Q2Q % growth | -0.29 | -0.30 | 0.01 | 3.07% |
| Q4 2021 Q2Q % growth | -0.29 -7.41% | -0.25 | -0.04 | -15.86% |
| Q3 2021 Q2Q % growth | -0.23 14.81% | -0.29 | 0.06 | 21.64% |
| Q2 2021 Q2Q % growth | -0.32 | -0.27 | -0.05 | -20.43% |
| Q1 2021 Q2Q % growth | -0.29 -3.57% | -0.25 | -0.04 | -14.18% |
| Q4 2020 Q2Q % growth | -0.27 30.77% | -0.26 | -0.01 | -3.40% |
| Q3 2020 Q2Q % growth | -0.27 | -0.22 | -0.05 | -21.15% |
| Q2 2020 Q2Q % growth | -0.32 | -0.32 | 0.00 | -1.20% |
| Q1 2020 Q2Q % growth | -0.28 6.67% | -0.40 | 0.12 | 29.61% |
| Q4 2019 Q2Q % growth | -0.39 | -0.29 | -0.10 | -36.55% |
| Q1 2019 Q2Q % growth | -0.30 | -0.37 | 0.07 | 18.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3.77% | -2.87% | 0% | -1.26% |
| Revenue | N/A | N/A | 0% | -15.23% |